Archive \ Volume.15 2024 Issue 4

Hybrid Revascularization in Treatment of Patients with Multilevel Vascular Lesion of Lower Extremities of Atherosclerotic Genesis

Ahmed Aslanov*✉ , Rustam Kalibatov , Oksana Logvina , Azamat Batov , Adam Apikov , Liana Kardanova , Ahmed Kugotov , Zalim Bakov , Zalim Baksanokov , Liza Taukenova , Artur Zhirikov
  1. Department of Therapy, Republican Clinical Medical and Surgical Center, Ministry of Health of Kabardino-Balkarian Republic, Nalchik, Russia.

  2. Department of Therapy, Faculty of Medicine, Kabardino-Balkarian State University named after Kh. M. Berbekov, Nalchik, Russia.

  3. Scientific Department, Ministry of Health of Kabardino-Balkarian Republic, Nalchik, Russia.

  4. Department of Therapy, Republican Clinical Multidisciplinary Center of High Medical Technologies, Ministry of Health of Kabardino-Balkarian Republic, Nalchik, Russia.

  5. Department of Therapy, Central Hospital of Tersk District, Nalchik, Russia.
  6. Department of Therapy, Oncological Dispensary, Ministry of Health of Kabardino-Balkarian Republic, Nalchik, Russia.

Abstract

This study aimed to evaluate the results of "hybrid operations" in patients with multilevel lesions of the lower extremities. For this study, 26 patients who underwent "hybrid operations" from 2023 to 2024 were selected. Ultrasound Dopplerography, ultrasound duplex scanning, and CT angiography were used to study the main arteries of the lower extremities. All patients were divided into two groups. In the first group, the ilio-femoral segment underwent isolated open reconstruction. In the second group hybrid revascularization of the same segment was performed with multilevel lesions of the arteries of the lower extremities. It was found that performing open methods of revascularization of the distal bed is possible only in the presence of adequate outflow through the arteries of the lower leg, which has the advantage of hybrid operations. The traumatism of hybrid operations is less, which is better tolerated by patients with severe concomitant diseases. Notably, hybrid revascularization operations are the method of choice in patients with chronic lower limb ischemia of the IV degree, contributing to faster healing of trophic disorders and preservation of the limb for a longer period.


Downloads: 228
Views: 394

How to cite:
Vancouver
Aslanov A, Kalibatov R, Logvina O, Batov A, Apikov A, Kardanova L, et al. Hybrid Revascularization in Treatment of Patients with Multilevel Vascular Lesion of Lower Extremities of Atherosclerotic Genesis. Arch Pharm Pract. 2024;15(4):21-4. https://doi.org/10.51847/Dfcf6mz3gd
APA
Aslanov, A., Kalibatov, R., Logvina, O., Batov, A., Apikov, A., Kardanova, L., Kugotov, A., Bakov, Z., Baksanokov, Z., Taukenova, L., et al. (2024). Hybrid Revascularization in Treatment of Patients with Multilevel Vascular Lesion of Lower Extremities of Atherosclerotic Genesis. Archives of Pharmacy Practice, 15(4), 21-24. https://doi.org/10.51847/Dfcf6mz3gd

Download Citation
References
  1. Alharthi NS. Endocannabinoid system components: A crucial role in the regulation of disease. J Adv Pharm Educ Res. 2022;12(3-2022):72-81.
  2. Eltayeb LB. Vancomycin-resistant enterococci (VRE) isolated from hospitalized patients: Molecular characterization of the van B gene. J Adv Pharm Educ Res. 2022;12(3-2022):87-92.
  3. Shamaki GR, Markson F, Soji-Ayoade D, Agwuegbo CC, Bamgbose MO, Tamunoinemi BM. Peripheral artery disease: A comprehensive updated review. Curr Probl Cardiol. 2022;47(11):101082. doi:10.1016/j.cpcardiol.2021.101082
  4. Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: Contemporary epidemiology, management gaps, and future directions: A scientific statement from the American heart association. Circulation. 2021;144(9):e171-91. doi:10.1161/CIR.0000000000001005
  5. Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2024;149(24):e1313-410. doi:10.1161/CIR.0000000000001251
  6. Almalki GH, Rabah S, Arafa NM, Bahshwan SM. Immunohistochemical evaluation of the euphorbia inarticulata extract on liver and kidney tissues in hepatocellular carcinoma rats. Pharmacophore. 2022;13(2-2022):33-40.
  7. Almourgi MA, Alamri TM, Algashmari AF, Nassir RA, Alharthi AA, Alsharief QF. Prevalence of smokers among gastroesophageal reflux disease patients in western Saudi Arabia region. Pharmacophore. 2022;13(2-2022):96-100.
  8. Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19(7):456-74. doi:10.1038/s41569-021-00663-9
  9. Bonaca MP, Hamburg NM, Creager MA. Contemporary medical management of peripheral artery disease. Circ Res. 2021;128(12):1868-84. doi:10.1161/CIRCRESAHA.121.318258
  10. Narula N, Olin JW, Narula N. Pathologic disparities between peripheral artery disease and coronary artery disease. Arterioscler Thromb Vasc Biol. 2020;40(9):1982-9. doi:10.1161/ATVBAHA.119.312864
  11. Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M. Burden of coronary artery disease and peripheral artery disease: A literature review. Cardiovasc Ther. 2019;2019:8295054. doi:10.1155/2019/8295054
  12. Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ. Peripheral artery disease: Past, present, and future. Am J Med. 2019;132(10):1133-41. doi:10.1016/j.amjmed.2019.04.043
  13. Bevan GH, White Solaru KT. Evidence-based medical management of peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(3):541-53. doi:10.1161/ATVBAHA.119.312142
  14. Mandaglio-Collados D, Marín F, Rivera-Caravaca JM. Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment. Med Clin (Barc). 2023;161(8):344-50. doi:10.1016/j.medcli.2023.06.005
  15. De Luca L, Bonaca MP, Magnani G. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: A narrative review. Expert Rev Cardiovasc Ther. 2020;18(12):881-9. doi:10.1080/14779072.2020.1833719
  16. Tang QH, Chen J, Hu CF, Zhang XL. Comparison between endovascular and open surgery for the treatment of peripheral artery diseases: A meta-analysis. Ann Vasc Surg. 2020;62:484-95. doi:10.1016/j.avsg.2019.06.039
  17. Nguyen BT, Nguyen TT, Le UT. Nomophobia and stress among Vietnamese high school students in Covid-19 pandemic: A mediation model of loneliness. J Biochem Technol. 2022;13(1-2022):34-40.
  18. Kachenkova ES, Zbrueva YV, Tkacheva ES, Pravdov DM, Eremin MV, Romanova AV, et al. Hematological indicators of students who started races. J Biochem Technol. 2022;13(1-2022):7-12.
  19. Nash D, McClure G, Mastracci TM, Anand SS. Social deprivation and peripheral artery disease. Can J Cardiol. 2022;38(5):612-22. doi:10.1016/j.cjca.2021.12.011
  20. Holder TA, Gutierrez JA, Aday AW. Medical management of peripheral artery disease. Cardiol Clin. 2021;39(4):471-82. doi:10.1016/j.ccl.2021.06.001
  21. Alanazi AA, Wajdi FA, Al Issa MS, Fallatah AA, Shaker AO, AlHatim AA, et al. An overview on klinefelter’s: Clinical features and management in pediatric population. Int J Pharm Res Allied Sci. 2022;11(1-2022):1-5.
  22. Gaikwad SS, Choudhari VP. Efficacy and safety of combination therapy of zinc and silver oxide nanoparticles in streptozotocin-induced diabetic rats. Int J Pharm Res Allied Sci. 2022;11(3-2022):1-0.
  23. Cooke JP, Meng S. Vascular regeneration in peripheral artery disease. Arterioscler Thromb Vasc Biol. 2020;40(7):1627-34. doi:10.1161/ATVBAHA.120.312862
  24. Allison MA, Armstrong DG, Goodney PP, Hamburg NM, Kirksey L, Lancaster KJ, et al. Health disparities in peripheral artery disease: A scientific statement from the American heart association. Circulation. 2023;148(3):286-96. doi:10.1161/CIR.0000000000001153
  25. Athavale A, Fukaya E, Leeper NJ. Peripheral artery disease: Molecular mechanisms and novel therapies. Arterioscler Thromb Vasc Biol. 2024;44(6):1165-70. doi:10.1161/ATVBAHA.124.320195
  26. Belyaev NG, Rzhepakovsky IV, Timchenko LD, Areshidze DA, Simonov AN, Nagdalian AA, et al. Effect of training on femur mineral density of rats. Biochem Cell Arch. 2019;19(2):3549-52.
  27. Paisley MJ, Adkar S, Sheehan BM, Stern JR. Aortoiliac occlusive disease. Semin Vasc Surg. 2022;35(2):162-71. doi:10.1053/j.semvascsurg.2022.04.005
  28. Bierowski M, Galanis T, Majeed A, Mofid A. Peripheral artery disease: Overview of diagnosis and medical therapy. Med Clin North Am. 2023;107(5):807-22. doi:10.1016/j.mcna.2023.05.007
  29. Wahyu S, Basoeki AP, Abbas KA. Perioperative anesthetic management in suprarenal pheochromocytoma tumor resection. J Med Pharm Chem Res. 2024;6(9):1274-88. doi:10.48309/jmpcr.2024.447564.1139
  30. McDermott MM, Ho KJ, Alabi O, Criqui MH, Goodney P, Hamburg N, et al. Disparities in diagnosis, treatment, and outcomes of peripheral artery disease: JACC scientific statement. J Am Coll Cardiol. 2023;82(24):2312-28. doi:10.1016/j.jacc.2023.09.830
  31. Beckman JA, Schneider PA, Conte MS. Advances in revascularization for peripheral artery disease: Revascularization in PAD. Circ Res. 2021;128(12):1885-912. doi:10.1161/CIRCRESAHA.121.318261
  32. Manolis AA, Manolis TA, Melita H, Mikhailidis DP, Manolis AS. Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med. 2022;102:24-39. doi:10.1016/j.ejim.2022.05.004
  33. Pasławska A, Tomasik PJ. Lipoprotein(a)-60 years later-what do we know? Cells. 2023;12(20):2472. doi:10.3390/cells12202472
  34. Jiwangga D, Mastutik G, Mahyudin F, Meitavany EN, Juliana, Dwipayana MA, et al. In vitro enhancement of chondrogenic and epithelial genes differentiation of human adipose mesenchymal stem cells in decellularized xenograft tracheal scaffold: Implications for tracheal disease management. J Med Pharm Chem Res. 2025;7(3):393-409. doi:10.48309/jmpcr.2025.464103.1301
  35. Pabon M, Cheng S, Altin SE, Sethi SS, Nelson MD, Moreau KL, et al. Sex differences in peripheral artery disease. Circ Res. 2022;130(4):496-511. doi:10.1161/CIRCRESAHA.121.320702
  36. Divakaran S, Krawisz AK, Secemsky EA, Kant S. Sex and racial disparities in peripheral artery disease. Arterioscler Thromb Vasc Biol. 2023;43(11):2099-114. doi:10.1161/ATVBAHA.123.319399
  37. Lee RE, Patel A, Soon SXY, Chan SL, Yap CJQ, Chandramohan S, et al. One-year clinical outcomes of Rutherford 6 chronic limb-threatening ischemia patients undergoing lower limb endovascular revascularisation from Singapore. CVIR Endovasc. 2022;5(1):32. doi:10.1186/s42155-022-00306-1
  38. Martem'ianov SV, Uvarov EA, Safonova OV. Assessment of the patient's quality of life in the long-term postoperative period after reconstructions on lower extremity arteries. Angiol Sosud Khir. 2004;10(2):129-35.

 

 

 

 

 


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.